Related Experiment Video

Updated: Jun 13, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

Treatment of difficult epilepsy

A McTague1, R Appleton

  • 1Roald Dahl EEG Unit, Department of Neurology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK. amy.mctague@alderhey.nhs.uk

Archives of Disease in Childhood
|April 21, 2010
PubMed

Insights

Pediatric epilepsy management can be challenging, with 30% of children experiencing uncontrolled seizures despite antiepileptic drugs (AEDs). A holistic approach, accurate diagnosis, and consideration of surgery are crucial for difficult pediatric epilepsy cases.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Clinical Management

Background:

  • Most childhood epilepsies are manageable with antiepileptic drugs (AEDs).
  • A significant subset of children (at least 30%) present with difficult or intractable epilepsy.
  • These cases often involve co-occurring physical, educational, or behavioral issues.

Purpose of the Study:

  • To outline an effective management strategy for children with difficult or intractable epilepsy.
  • To emphasize the importance of accurate diagnosis and a comprehensive treatment approach.

Main Methods:

  • Accurate diagnosis of epilepsy type and syndrome.
  • Consideration of underlying causes.
  • Holistic assessment of the child's overall well-being.
  • Optimized antiepileptic drug (AED) regimen.
  • Evaluation of surgical candidacy.

Main Results:

  • Accurate diagnosis is the foundational step in managing difficult epilepsy.
  • A holistic approach, addressing the child as a whole, is essential.
  • Surgery is presented as a viable treatment option.

Conclusions:

  • Effective management of difficult pediatric epilepsy requires a multi-faceted strategy.
  • Accurate diagnosis, individualized AED treatment, and consideration of surgery are key components.
  • Addressing the child's comprehensive needs beyond seizures is paramount.

More Related Videos

Performing Behavioral Tasks in Subjects with Intracranial Electrodes12:10

Performing Behavioral Tasks in Subjects with Intracranial Electrodes

Published on: October 2, 2014

Stereo-Electro-Encephalo-Graphy (SEEG) With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note05:54

Stereo-Electro-Encephalo-Graphy (SEEG) With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note

Published on: June 13, 2016

Related Concept Videos

Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...